Vial A: Simultest Leucogate CD45/CD14, FITC-labeled CD45~0.025mg/mL, PE-labeled CD14~0.013mg/mL,Vial B: Simultest 1gG1/lgG2a Isotype Control, FITC-labeled IgG1~0.013mg/mL PE-labeled IgG2a~0.013mg/mL, Vial C: Simultest CD3/CD19, FITC-labeled CD3~0.025mg/mL, PE-labeled CD19~0.003mg/mLVial D: Simultest CD3/CD4, FITC-labeled CD3~0.025mg/mL, PE-labeled CD4~0.002mg/mLVial E: Simultest CD3/CD8, FITC-labeled CD3~0.025mg/mL, PE-labeled CD8~0.006mg/mLVial F: Simultest CD3/CD16+CD56, FITC-labeled CD3~0.025mg/mL, PE-labeled CD16~0.006mg/mL, PE-labeled CD56~0.013mg/mLVial G: 10X FACS Lysing Solution, Contains<15% formaldehyde, <50% diethylene glycol, sodium citrate, and heparin.

共有 1 個藥物證書使用此成份

申請商
新加坡商必帝股份有限公司台灣分公司 
適應症
含量
發證日期
2005-06-29